Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The Combination of PARP Inhibitors and DNMT Inhibitors Modulates Immune Activity and Suggests a Role for Immune Therapy in AML

Aksinija A Kogan, BS, MS, Michael Topper, BS, Susannah C Shissler, BS, Michael S Lee, BS, Dominique R Bollino, BS, Eun Yong Choi, Rena G Lapidus, PhD, Li Li, MD PhD, Donald Small, MD PhD, Maria R. Baer, MD, Tonya J Webb, PhD, Stephen Baylin, MD, Feyruz V. Rassool, BSc, PhD

Blood (2018) 132 (Supplement 1): 3886.

https://doi.org/10.1182/blood-2018-99-117294

Published: 2018

Journal Articles

Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma

Shaji Kumar, Ian Flinn, Paul G. Richardson, Parameswaran Hari, Natalie Callander, Stephen J. Noga, A. Keith Stewart, Francesco Turturro, Robert Rifkin, Jeffrey Wolf, Jose Estevam, George Mulligan, Hongliang Shi, Iain J. Webb, S. Vincent Rajkumar

Blood (2012) 119 (19): 4375–4382.

https://doi.org/10.1182/blood-2011-11-395749

Published: 2012

Journal Articles

Novel Three- and Four-Drug Combination Regimens of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Previously Untreated Multiple Myeloma: Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study

Shaji Kumar, MD, Ian W. Flinn, MD, PhD, Paul G Richardson, MD, Parameswaran Hari, MD, Natalie Scott Callander, MD, Stephen J. Noga, MD, PhD, A. Keith Stewart, MD, Jonathan Glass, MD, FACP, Robert M. Rifkin, MD, Jeffrey L Wolf, MD, Jose Estevam, BS, George Mulligan, PhD, Hongliang Shi, MS, Iain J. Webb, MD, FRCPC, S. Vincent Rajkumar, MD

Blood (2010) 116 (21): 621.

https://doi.org/10.1182/blood.V116.21.621.621

Published: 2010

Journal Articles

High Complete and Very Good Partial Response Rates with Bortezomib—Dexamethasone as Induction Prior to ASCT in Newly Diagnosed Patients with High-Risk Myeloma: Results of the IFM2005-01 Phase 3 Trial.

Jean-Luc Harousseau, Herve Avet-Loiseau, Michel Attal, Gerald Marit, Denis Caillot, Cyrille Hulin, Thierry Facon, Iain J. Webb, Claire Mathiot, Philippe Moreau

Blood (2009) 114 (22): 353.

https://doi.org/10.1182/blood.V114.22.353.353

Published: 2009

Journal Articles

Novel Three– and Four–Drug Combinations of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Newly Diagnosed Multiple Myeloma: Encouraging Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study.

Shaji Kumar, Ian W. Flinn, Parameswaran N. Hari, Natalie Callander, Stephen J. Noga, A. Keith Stewart, Jonathan Glass, Noopur Raje, Robert M. Rifkin, Hongliang Shi, Iain J. Webb, Paul G. Richardson, S. Vincent Rajkumar

Blood (2009) 114 (22): 127.

https://doi.org/10.1182/blood.V114.22.127.127

Published: 2009

Journal Articles

Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

Shaji Kumar, MD, Ian W Flinn, MD, PhD, Stephen J. Noga, MD, PhD, Parameswaran Hari, MD, MS, Robert M. Rifkin, MD, Natalie Scott Callander, MD, Manish Bhandari, MD, Jeffrey Lee Wolf, MD, Cristina Gasparetto, MD, Amrita Krishnan, MD, FACP, Daren D Grosman, MD, PhD, Jonathan Glass, MD, Entezam Asim Sahovic, MD, Hongliang Shi, MS, Iain J. Webb, MD, Paul Richardson, MD, S. Vincent Rajkumar, MD

Blood (2008) 112 (11): 93.

https://doi.org/10.1182/blood.V112.11.93.93

Published: 2008

Journal Articles

Phase 1/2 Study of Tandutinib (MLN518) Plus Standard Induction Chemotherapy in Newly Diagnosed Acute Myelogenous Leukemia (AML).

Daniel J. DeAngelo, MD, PhD, Philip C. Amrein, MD, Tibor J. Kovacsovics, MD, Rebecca B. Klisovic, Bayard L. Powell, MD, Michael Cooper, MD, Iain J. Webb, Richard M. Stone, MD

Blood (2006) 108 (11): 158.

https://doi.org/10.1182/blood.V108.11.158.158

Published: 2006

Journal Articles

Nitrite Is Reduced to Nitric Oxide by Xanthine Oxidoreductase and Nitric Oxide Synthase in the Erythrocyte Membrane in Hypoxemia.

Krishnaraj S. Rathod, BMedSci, Andrew J. Webb, MBBS, Matthew J. Lovell, MBBS, Florence Lecomte, MA, Amrita Ahluwalia, PhD

Blood (2006) 108 (11): 1560.

https://doi.org/10.1182/blood.V108.11.1560.1560

Published: 2006

Journal Articles

Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells

Susan K. Nilsson, Hayley M. Johnston, Genevieve A. Whitty, Brenda Williams, Ryan J. Webb, David T. Denhardt, Ivan Bertoncello, Linda J. Bendall, Paul J. Simmons, David N. Haylock

Blood (2005) 106 (4): 1232–1239.

https://doi.org/10.1182/blood-2004-11-4422

Published: 2005

Journal Articles

Bone Marrow and Peripheral Blood Dendritic Cells From Patients With Multiple Myeloma Are Phenotypically and Functionally Normal Despite the Detection of Kaposi’s Sarcoma Herpesvirus Gene Sequences

Noopur Raje, Jianlin Gong, Dharminder Chauhan, Gerrard Teoh, David Avigan, Zekui Wu, Dongshu Chen, Steven P. Treon, Iain J. Webb, Donald W. Kufe, Kenneth C. Anderson

Blood (1999) 93 (5): 1487–1495.

https://doi.org/10.1182/blood.V93.5.1487

Published: 1999

Journal Articles

Adenovirus Vector-Based Purging of Multiple Myeloma Cells

Gerrard Teoh, Ling Chen, Mitsuyoshi Urashima, Yu-Tzu Tai, Leo A. Celi, Dongshu Chen, Dharminder Chauhan, Atsushi Ogata, Robert W. Finberg, Iain J. Webb, Donald W. Kufe, Kenneth C. Anderson

Blood (1998) 92 (12): 4591–4601.

https://doi.org/10.1182/blood.V92.12.4591

Published: 1998

Journal Articles

Anti-Estrogens Induce Apoptosis of Multiple Myeloma Cells

Steven P. Treon, Gerrard Teoh, Mitsuyoshi Urashima, Atsushi Ogata, Dharminder Chauhan, Iain J. Webb, Kenneth C. Anderson

Blood (1998) 92 (5): 1749–1757.

https://doi.org/10.1182/blood.V92.5.1749

Published: 1998

Journal Articles

Absence of Immunogenicity of Diaspirin Cross-Linked Hemoglobin in Humans

Mehul J. Patel, Edwin J. Webb, Tina E. Shelbourn, Cynthia Mattia-Goldberg, Andrew J.T. George, Feng Zhang, Edwin G. Moore, Deanna J. Nelson

Blood (1998) 91 (2): 710–716.

https://doi.org/10.1182/blood.V91.2.710

Published: 1998

Journal Articles

A mono-sited transferrin from a representative deuterostome: the ascidian Pyura stolonifera (subphylum Urochordata)

AW Martin, E Huebers, H Huebers, J Webb, CA Finch

Blood (1984) 64 (5): 1047–1052.

https://doi.org/10.1182/blood.V64.5.1047.1047

Published: 1984

NARROW

The Combination of PARP Inhibitors and DNMT Inhibitors Modulates Immune Activity and Suggests a Role for Immune Therapy in AML

Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma

Novel Three- and Four-Drug Combination Regimens of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Previously Untreated Multiple Myeloma: Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study

High Complete and Very Good Partial Response Rates with Bortezomib—Dexamethasone as Induction Prior to ASCT in Newly Diagnosed Patients with High-Risk Myeloma: Results of the IFM2005-01 Phase 3 Trial.

Novel Three– and Four–Drug Combinations of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Newly Diagnosed Multiple Myeloma: Encouraging Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study.

Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

Phase 1/2 Study of Tandutinib (MLN518) Plus Standard Induction Chemotherapy in Newly Diagnosed Acute Myelogenous Leukemia (AML).

Nitrite Is Reduced to Nitric Oxide by Xanthine Oxidoreductase and Nitric Oxide Synthase in the Erythrocyte Membrane in Hypoxemia.

Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells

Bone Marrow and Peripheral Blood Dendritic Cells From Patients With Multiple Myeloma Are Phenotypically and Functionally Normal Despite the Detection of Kaposi’s Sarcoma Herpesvirus Gene Sequences

Adenovirus Vector-Based Purging of Multiple Myeloma Cells

Anti-Estrogens Induce Apoptosis of Multiple Myeloma Cells

Absence of Immunogenicity of Diaspirin Cross-Linked Hemoglobin in Humans

A mono-sited transferrin from a representative deuterostome: the ascidian Pyura stolonifera (subphylum Urochordata)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only